My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
COMPLIANCE INFO_1975-2013
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
T
>
TRACY
>
1420
>
4500 - Medical Waste Program
>
PR0450009
>
COMPLIANCE INFO_1975-2013
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/20/2022 12:55:09 PM
Creation date
7/3/2020 10:18:09 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
4500 - Medical Waste Program
File Section
COMPLIANCE INFO
FileName_PostFix
1975-2013
RECORD_ID
PR0450009
PE
4522
FACILITY_ID
FA0002562
FACILITY_NAME
Sutter Valley Hospitals dba Sutter Tracy Community Hospital
STREET_NUMBER
1420
Direction
N
STREET_NAME
TRACY
STREET_TYPE
Blvd
City
Tracy
Zip
95376
APN
233-081-01
CURRENT_STATUS
01
SITE_LOCATION
1420 N Tracy Blvd
P_LOCATION
03
P_DISTRICT
005
QC Status
Approved
Scanner
SJGOV\cfield
Supplemental fields
FilePath
\MIGRATIONS\MW\MW_4522_PR0450009_1420 N TRACY_1975-2015tif
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
198
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
State of Califomia-Health and Human Ses Agency <br />RADIOACTIVE MATERIAL LICENSE <br />Department of Health Services <br />Page 3 of 4 pages <br />License Number. 4097-39 <br />Amendment Number. 19 <br />17. The following individuals are authorized to collect wipe test samples of sealed sources possessed under this license <br />using leak test kits acceptable to the California Department of Health Services: <br />(a) The Radiation Safety Officer <br />(b) Qualified individuals designated in writing by the Radiation Safety Officer <br />18. Except for alpha sources, the periodic leak test required by Condition 15 does not apply to sealed sources that are <br />stored and not being used. The sources excepted from this test shall be tested for leakage prior to any use or transfer <br />to another person unless they have been leak tested within six months prior to the date of use or transfer. <br />19. The licensee shall conduct a physical inventory every six months to account for all sealed sources and/or devices <br />received and possessed under the license. Records of the inventories shall be maintained for inspection, and may be <br />disposed of following Department inspection. <br />20. The licensee is authorized to hold radioactive materials with a physical half-life of less than 65 days for decay in <br />storage before disposal in ordinary trash provided: <br />(a) Radioactive waste to be disposed of in this manner shall be held for decay in storage for at least 10 half-lives. <br />(b) Before disposal as normal waste, radioactive waste shall be surveyed to determine that its radioactivity cannot <br />be distinguished from background. All radiation labels shall be removed or obliterated. <br />21. The licensee may use one constancy source for the dose calibrator constancy test provided that the dose, <br />calibrator manual indicates that only one constancy source is needed for proper Quality. Control. <br />22. The licensee may use any commercially available device, acceptable to the U.S. Nuclear Regulatory Commission, an <br />Agreement State or a Licensing State, for doing linearity tests of its dose calibrator provided the procedures <br />described by the manufacturer of the linearity device are followed. <br />23. Nuclear medicine technology procedures shall be performed by nuclear medicine technologists pursuant to Title 17, <br />California Code of Regulations, Subchapter 4.6. Such procedures shall be performed under the supervision of <br />authorized user physicians on this license who meet the criteria specified in Section 30510. Certificates or special <br />permits issued pursuant to Subchapter 4.6 shall be prominently displayed at the facility(ies) authorized on this <br />license. <br />24. Treatment and management of patients receiving therapeutic quantities of unsealed radioactive materials shall be in <br />accordance with the guidance from any of the following: <br />(a) Chapter 4, "Release from Hospital of Patients Containing Radioactive Material" National Council on Radiation <br />Protection and Measurements (NCRP) Report No. 37, "Precautions in the Management of Patients Who Have <br />Received Therapeutic Amounts of Radionuclides" (NCRP Publications, P.O. Box 30175, Washington, D.C. <br />20014). <br />(b) Appendix M in the "Guide for the Preparation of Applications for Medical Programs", State of California, <br />Department of Health Services, Radiological Health Branch. <br />(c) Documented rationale or patient -specific calculations demonstrating that members of the general public will be <br />limited to 500 mrem total effective dose equivalent from patients who have been released containing therapeutic <br />quantities of radiopharmaceuticals. <br />
The URL can be used to link to this page
Your browser does not support the video tag.